English
  1. Home
  2. Stocks
  3. Biocon Share Price
  • Chart
  • F&O
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Biocon

    Large Cap
    ₹335.95
    -14.4 (-4.11%)
    • Advice
    • Hold
    22 December, 2024 06:46 BSE: 532523 NSE: BIOCONISIN: INE376G01013

    Start SIP in Biocon

    Start SIP

    Biocon Performance

    Day Range

    ₹ 335

    52 Week Range

    ₹ 335

    Biocon Share Price

    • Over 1 Month +2.72%
    • Over 3 Month -8.05%
    • Over 6 Month -2%
    • Over 1 Year +38.48%

    Biocon Key Statistics

    Biocon F&O

    Biocon Futures Biocon Option Chain
    Invest in Biocon

    Biocon Technicals

    EMA & SMA

    Current Price
    ₹335.95
    -14.4 (-4.11%)
    pointer
    • Bullish Moving Average
    • ___
    • 2
    • Bearish Moving Average
    • ___
    • 14
    • 20 Day
    • ₹353.63
    • 50 Day
    • ₹349.95
    • 100 Day
    • ₹345.40
    • 200 Day
    • ₹330.27
    • 20 Day
    • ₹360.80
    • 50 Day
    • ₹342.60
    • 100 Day
    • ₹350.86
    • 200 Day
    • ₹329.46

    Biocon Resistance and Support

    PIVOT
    ₹340.8
    Resistance
    First Resistance 346.45
    Second Resistance 356.95
    Third Resistance 362.60
    RSI 38.88
    MFI 30.07
    MACD Single Line 4.79
    MACD 0.80
    Support
    First Support 330.30
    Second Support 324.65
    Third Supoort 314.15

    Biocon Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 2,961,246 133,463,357 45.07
    Week 2,390,264 94,200,304 39.41
    1 Month 3,037,440 107,130,514 35.27
    6 Month 4,631,990 169,345,558 36.56

    Biocon Result Highlights

    Biocon Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Biocon Corporate Action

    Date Purpose Remarks
    2024-10-30 Quarterly Results
    2024-08-08 Quarterly Results
    2024-05-16 Audited Results & Final Dividend
    2024-02-08 Quarterly Results
    2023-11-10 Quarterly Results
    Date Purpose Remarks
    2024-07-05 FINAL Rs.0.50 per share(10%)Final Dividend
    2023-07-07 FINAL Rs.1.50 per share(30%)Final Dividend
    2022-07-01 FINAL Rs.0.50 per share(10%)Final Dividend

    About Biocon

    Biocon limited is a biopharmaceutical company in India and it is Asia's largest biotechnology company. The company was founded by Kiran Mazumdar-Shaw in 1978 and is headquartered in Bangalore, India. The company has more than 13,500  employees. It focuses on all phases of the product cycle from researching to development and then introducing them to the market.  They mainly concentrate on the research and development of advanced therapies for the treatment of cancer, diabetes, and autoimmune disease. The company's medicines are helping the lives of patients in more than 120 countries by providing access to all their medicines and therapies. 

    Some of Biocon's important brands in India are INSUGEN (rh-insulin), BIOMAb EGFR (Nimotuzumab), CANMAb (Trastuzumab),KRABEVA (Bevacizumab), ALZUMAb(Itolizumab), BLISTO (Glimepiride + Metformin), BASALOG (Glargine), etc. 

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.